Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum β-lactamases: A prospective study with Swedish volunteers

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 9, 2010, Pages 3564-3568

  Tängdén, Thomas ^a   Cars, Otto ^a   Melhus, Åsa ^a   Löwdin, Elisabeth ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE CTX M; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MECILLINAM; MEROPENEM; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; SULFADOXINE PLUS TRIMETHOPRIM; TETRACYCLINE DERIVATIVE; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CHILD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EUROPE; FEMALE; FOLLOW UP; GASTROENTERITIS; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; TRAVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TRAVEL; YOUNG ADULT;

EID: 77956102466     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00220-10     Document Type: Article

References (33)

1. Apisarnthanarak, A., T. C. Bailey, and V. J. Fraser. 2008. Duration of stool colonization in patients infected with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 46:1322-1323.
2. Baquero, F., P. R. Hsueh, D. L. Paterson, F. Rossi, G. V. Bochicchio, G. Gallagher, K. Lantz, J. B. Villasenor, K. McCarroll, M. A. Abramson, and J. W. Chow. 2009. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2005 results from Study for Monitoring Antimicrobial Resistance Trends (SMART). Surg. Infect. (Larchmt.) 10:99-104.
3. Bush, K. 2008. Extended-spectrum beta-lactamases in North America, 1987-2006. Clin. Microbiol. Infect. 14 (Suppl. 1):134-143.
4. Canton, R., A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, and T. M. Coque. 2008. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14(Suppl. 1):144-153.
5. Colodner, R., W. Rock, B. Chazan, N. Keller, N. Guy, W. Sakran, and R. Raz. 2004. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 23:163-167.
6. Durkalski, V. L., Y. Y. Palesch, S. R. Lipsitz, and P. F. Rust. 2003. Analysis of clustered matched-pair data. Stat. Med. 22:2417-2428.
7. European Antimicrobial Resistance Surveillance System. 2006. Annual report 2005. National Institute of Public Health and the Environment, Bilthoven, Netherlands.
8. Freeman, J. T., S. J. McBride, H. Heffernan, T. Bathgate, C. Pope, and R. B. Ellis-Pegler. 2008. Community-onset genitourinary tract infection due to CTX-M-15-producing Escherichia coli among travelers to the Indian sub-continent in New Zealand. Clin. Infect. Dis. 47:689-692.
9. Goossens, H., and B. Grabein. 2005. Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn. Microbiol. Infect. Dis. 53:257-264.
10. Hawkey, P. M. 2008. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin. Microbiol. Infect. 14(Suppl. 1):159-165.
11. Hirakata, Y., J. Matsuda, Y. Miyazaki, S. Kamihira, S. Kawakami, Y. Miyazawa, Y. Ono, N. Nakazaki, Y. Hirata, M. Inoue, J. D. Turnidge, J. M. Bell, R. N. Jones, and S. Kohno. 2005. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn. Microbiol. Infect. Dis. 52:323-329.
12. Ho, P. L., W. W. Poon, S. L. Loke, M. S. Leung, K. H. Chow, R. C. Wong, K. S. Yip, E. L. Lai, and K. W. Tsang. 2007. Community emergence of CTX-M type extended-spectrum beta-lactamases among urinary Escherichia coli from women. J. Antimicrob. Chemother. 60:140-144.
13. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
14. Kader, A. A., A. Kumar, and K. A. Kamath. 2007. Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect. Control Hosp. Epidemiol. 28:1114-1116.
15. Laupland, K. B., D. L. Church, J. Vidakovich, M. Mucenski, and J. D. Pitout. 2008. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J. Infect. 57:441-448.
16. Laupland, K. B., D. B. Gregson, D. L. Church, T. Ross, and J. D. Pitout. 2008. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin. Microbiol. Infect. 14:1041-1047.
17. Lytsy, B., L. Sandegren, E. Tano, E. Torell, D. I. Andersson, and A. Melhus. 2008. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 116:302-308. (Pubitemid 351499162)
18. Mathai, D., P. R. Rhomberg, D. J. Biedenbach, and R. N. Jones. 2002. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagn. Microbiol. Infect. Dis. 44:367-377.
19. Munday, C. J., J. Xiong, C. Li, D. Shen, and P. M. Hawkey. 2004. Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China. Int. J. Antimicrob. Agents 23:175-180.
20. Norskov-Lauritsen, N., H. Marchandin, and M. J. Dowzicky. 2009. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007). Int. J. Antimicrob. Agents 34:121-130.
21. Pitout, J. D., L. Campbell, D. L. Church, D. B. Gregson, and K. B. Laupland. 2009. Molecular characteristics of travel-related extended-spectrum- beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region. Antimicrob. Agents Chemother. 53:2539-2543.
22. Pitout, J. D., A. Hossain, and N. D. Hanson. 2004. Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 42:5715-5721.
23. Rodriguez-Bano, J., L. Lopez-Cerero, M. D. Navarro, P. Diaz de Alba, and A. Pascual. 2008. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J. Antimicrob. Chemother. 62:1142-1149.
24. Rodriguez-Bano, J., M. D. Navarro, L. Romero, L. Martinez-Martinez, M. A. Muniain, E. J. Perea, R. Perez-Cano, and A. Pascual. 2004. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase- producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42:1089-1094.
25. Rodriguez-Bano, J., M. D. Navarro, L. Romero, M. A. Muniain, M. Cueto, J. Galvez, E. J. Perea, and A. Pascual. 2008. Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Clin. Microbiol. Infect. 14:180-183.
26. Rossolini, G. M., M. M. D'Andrea, and C. Mugnaioli. 2008. The spread of CTX-M-type extended-spectrum beta-lactamases. Clin. Microbiol. Infect. 14(Suppl. 1):33-41.
27. Struwe, J., and B. Olsson-Liljequist. 2009. Short summary of Swedres 2008, a report on antimicrobial utilisation and resistance in humans in Sweden. Euro Surveill. 14(25):pii=19252.http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19252.
28. Svenungsson, B., A. Lagergren, E. Ekwall, B. Evengard, K. O. Hedlund, A. Karnell, S. Lofdahl, L. Svensson, and A. Weintraub. 2000. Enteropathogens in adult patients with diarrhea and healthy control subjects: a 1-year prospective study in a Swedish clinic for infectious diseases. Clin. Infect. Dis. 30:770-778.
29. Tham, J., I. Odenholt, M. Walder, A. Brolund, J. Ahl, and E. Melander. 2010. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea. Scand. J. Infect. Dis. 42:275-280.
30. Valverde, A., T. M. Coque, M. P. Sanchez-Moreno, A. Rollan, F. Baquero, and R. Canton. 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol. 42:4769-4775.
31. Villegas, M. V., J. N. Kattan, M. G. Quinteros, and J. M. Casellas. 2008. Prevalence of extended-spectrum beta-lactamases in South America. Clin. Microbiol. Infect. 14(Suppl. 1):154-158.
32. Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32(Suppl. 2):S94-S103.
33. Yang, J. R., F. T. Wu, J. L. Tsai, J. J. Mu, L. F. Lin, K. L. Chen, S. H. Kuo, C. S. Chiang, and H. S. Wu. 2007. Comparison between O serotyping method and multiplex real-time PCR to identify diarrheagenic Escherichia coli in Taiwan. J. Clin. Microbiol. 45:3620-3625.